$AGIO
Agios Pharmaceuticals Inc Stock $agio

$agio Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000143922219000009 Filed on May 02, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$26.22M	$30.23M	$8.762M
YoY Change	-35.12%	244.98%	-16.62%
Cost Of Revenue	$303.0K	$334.0K	$0.00
YoY Change
Gross Profit	$25.92M	$29.89M	$8.762M
YoY Change	-35.87%	241.17%
Gross Profit Margin	98.84%	98.9%	100.0%
Selling, General & Admin	$32.39M	$31.79M	$24.55M
YoY Change	21.63%	29.49%	65.65%
% of Gross Profit	124.97%	106.35%	280.19%
Research & Development	$107.4M	$95.59M	$78.22M
YoY Change	23.82%	22.19%	24.7%
% of Gross Profit	414.34%	319.76%	892.76%
Depreciation & Amortization	$2.000M	$2.005M	$1.725M
YoY Change	11.11%	16.23%	8.42%
% of Gross Profit	7.72%	6.71%	19.69%
Operating Expenses	$140.1M	$127.7M	$102.8M
YoY Change	23.57%	24.26%	32.52%
Operating Profit	-$113.9M	-$97.48M	-$94.01M
YoY Change	56.08%	3.69%	40.22%
Interest Expense	$3.990M	$4.410M	$3.190M
YoY Change	-5.0%	38.24%	262.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$109.9M	-$93.08M	-$90.83M
YoY Change	59.81%	2.48%	37.27%
Income Tax
% Of Pretax Income
Net Earnings	-$109.9M	-$93.08M	-$90.83M
YoY Change	59.82%	2.48%	37.27%
Net Earnings / Revenue	-419.02%	-307.93%	-1036.58%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.871M	-$1.592M	-$1.631M
COMMON SHARES
Basic Shares Outstanding	58.71M shares	58.40M shares	57.33M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$495.4M	$524.6M	$782.5M
YoY Change	-30.9%	-32.96%	63.09%
Cash & Equivalents	$83.58M	$103.4M	$364.5M
Short-Term Investments	$411.8M	$421.1M	$418.0M
Other Short-Term Assets	$19.10M	$19.70M	$15.60M
YoY Change	23.23%	26.28%	25.81%
Inventory	$4.659M	$2.328M
Prepaid Expenses
Receivables	$9.800M	$6.600M	$1.400M
Other Receivables	$4.800M	$3.900M	$3.500M
Total Short-Term Assets	$533.7M	$557.1M	$803.0M
YoY Change	-29.2%	-30.62%	58.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.02M	$23.97M	$23.73M
YoY Change	-4.63%	1.02%	-1.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$128.6M	$183.2M	$212.3M
YoY Change	-41.47%	-13.71%	807.26%
Other Assets	$0.00	$60.00K	$1.104M
YoY Change	-100.0%	-94.57%	-61.77%
Total Long-Term Assets	$250.2M	$265.0M	$237.1M
YoY Change	2.34%	11.77%	370.04%
TOTAL ASSETS
Total Short-Term Assets	$533.7M	$557.1M	$803.0M
Total Long-Term Assets	$250.2M	$265.0M	$237.1M
Total Assets	$783.9M	$822.1M	$1.040B
YoY Change	-21.47%	-20.96%	86.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.44M	$12.41M	$17.93M
YoY Change	-10.88%	-30.78%	11.02%
Accrued Expenses	$49.22M	$37.20M	$17.01M
YoY Change	90.82%	118.75%	-32.29%
Deferred Revenue	$18.45M	$22.17M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$89.50M	$80.91M	$74.70M
YoY Change	5.46%	8.31%	-9.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$161.7M	$121.0M	$99.80M
YoY Change	79.27%	21.24%	-40.42%
Total Long-Term Liabilities	$161.7M	$121.0M	$99.80M
YoY Change	79.27%	21.24%	-40.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$89.50M	$80.91M	$74.70M
Total Long-Term Liabilities	$161.7M	$121.0M	$99.80M
Total Liabilities	$251.2M	$201.9M	$174.5M
YoY Change	43.46%	15.67%	-30.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.308B	-$1.198B	-$758.6M
YoY Change	42.41%	57.88%	38.04%
Common Stock	$1.840B	$1.818B	$1.718B
YoY Change	5.51%	5.87%	100.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$532.7M	$620.3M	$865.6M
YoY Change
Total Liabilities & Shareholders Equity	$783.9M	$822.1M	$1.040B
YoY Change	-21.47%	-20.96%	86.63%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$109.9M	-$93.08M	-$90.83M
YoY Change	59.82%	2.48%	37.27%
Depreciation, Depletion And Amortization	$2.000M	$2.005M	$1.725M
YoY Change	11.11%	16.23%	8.42%
Cash From Operating Activities	-$88.10M	-$103.3M	-$99.00M
YoY Change	30.71%	4.31%	33.65%
INVESTING ACTIVITIES
Capital Expenditures	-$1.300M	$2.038M	$1.432M
YoY Change	-7.14%	42.32%	388.74%
Acquisitions
YoY Change
Other Investing Activities	$65.70M	$133.4M	-$166.1M
YoY Change	-169.23%	-180.31%	-251.28%
Cash From Investing Activities	$64.40M	$131.4M	-$167.5M
YoY Change	-166.87%	-178.4%	-252.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$516.2M
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.800M	$4.860M	$528.3M
YoY Change	-60.0%	-99.08%	12956.77%
NET CHANGE
Cash From Operating Activities	-88.10M	-$103.3M	-$99.00M
Cash From Investing Activities	64.40M	$131.4M	-$167.5M
Cash From Financing Activities	3.800M	$4.860M	$528.3M
Net Change In Cash	-19.90M	$32.94M	$261.7M
YoY Change	-87.09%	-87.41%	562.24%
FREE CASH FLOW
Cash From Operating Activities	-$88.10M	-$103.3M	-$99.00M
Capital Expenditures	-$1.300M	$2.038M	$1.432M
Free Cash Flow	-$86.80M	-$105.3M	-$100.4M
YoY Change	31.52%	4.86%	35.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	AGIOS PHARMACEUTICALS INC
CY2019Q1	dei	Trading Symbol TradingSymbol	AGIO
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001439222
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58659821	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58218653	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58659821	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58218653	shares
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58711333	shares
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103443000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70502000	USD
CY2019Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	421114000	USD
CY2018Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	514800000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4355000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5076000	USD
CY2019Q1	agio	Collaboration Receivable Duefrom Related Parties Current CollaborationReceivableDuefromRelatedPartiesCurrent	2319000	USD
CY2018Q4	agio	Collaboration Receivable Duefrom Related Parties Current CollaborationReceivableDuefromRelatedPartiesCurrent	2462000	USD
CY2019Q1	agio	Collaboration Receivable Other Current CollaborationReceivableOtherCurrent	1640000	USD
CY2018Q4	agio	Collaboration Receivable Other Current CollaborationReceivableOtherCurrent	670000	USD
CY2019Q1	agio	Royalty Receivable Duefrom Related Parties Current RoyaltyReceivableDuefromRelatedPartiesCurrent	2200000	USD
CY2018Q4	agio	Royalty Receivable Duefrom Related Parties Current RoyaltyReceivableDuefromRelatedPartiesCurrent	2234000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	2328000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	869000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19696000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17167000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	557095000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	613780000	USD
CY2019Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	183234000	USD
CY2018Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	220119000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	57768000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23974000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24320000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	238000	USD
CY2019Q1	us-gaap	Assets Assets	822131000	USD
CY2018Q4	us-gaap	Assets Assets	858457000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12413000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17880000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37199000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42147000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22167000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	32710000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9128000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	0	USD
CY2018Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	766000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	80907000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	93503000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54961000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	59809000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	66006000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	17608000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	201874000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	170920000	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	59000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1818393000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1794283000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-484000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2171000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1197711000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1104633000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	620257000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	687537000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	822131000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	858457000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30227000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8762000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	334000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	95585000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78224000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31791000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24550000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	127710000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	102774000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-97483000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-94012000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4405000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3187000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-93078000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-90825000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.59
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.63
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58453918	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55694603	shares
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-93078000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-90825000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1687000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1254000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91391000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92079000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	687537000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1687000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-93078000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18108000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6003000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	620257000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	375503000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1254000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-90825000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14522000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12332000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	516206000	USD
CY2018Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-346000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	865594000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-93078000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-90825000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	2005000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	1725000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18108000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14522000	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1131000	USD
CY2018Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	406000	USD
CY2019Q1	agio	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	2085000	USD
CY2019Q1	agio	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-721000	USD
CY2018Q1	agio	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
CY2019Q1	agio	Increase Decreasein Collaboration Receivable Duefrom Related Parties Current IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent	-143000	USD
CY2018Q1	agio	Increase Decreasein Collaboration Receivable Duefrom Related Parties Current IncreaseDecreaseinCollaborationReceivableDuefromRelatedPartiesCurrent	1064000	USD
CY2019Q1	agio	Increase Decreasein Collaboration Receivable Other Current IncreaseDecreaseinCollaborationReceivableOtherCurrent	970000	USD
CY2018Q1	agio	Increase Decreasein Collaboration Receivable Other Current IncreaseDecreaseinCollaborationReceivableOtherCurrent	0	USD
CY2019Q1	agio	Increase Decreasein Royalty Receivable Duefrom Related Parties Current IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent	-34000	USD
CY2018Q1	agio	Increase Decreasein Royalty Receivable Duefrom Related Parties Current IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent	195000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1459000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2173000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1901000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4939000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4469000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-5097000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-17144000	USD
CY2019Q1	agio	Increase Decrease In Contract With Customer Liability Related Party IncreaseDecreaseInContractWithCustomerLiabilityRelatedParty	-15391000	USD
CY2018Q1	agio	Increase Decrease In Contract With Customer Liability Related Party IncreaseDecreaseInContractWithCustomerLiabilityRelatedParty	-3141000	USD
CY2019Q1	agio	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2129000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-96000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-103271000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-99000000	USD
CY2019Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	77421000	USD
CY2018Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	330971000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	210811000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	164871000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2038000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1432000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	131352000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167532000	USD
CY2019Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	188000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	516206000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4860000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	12259000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4860000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	528277000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32941000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	261745000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70502000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102724000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103443000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364469000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	727000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	605000	USD
CY2019Q1	agio	Proceeds From Stock Options Exercised In Other Current Assets ProceedsFromStockOptionsExercisedInOtherCurrentAssets	1149000	USD
CY2018Q1	agio	Proceeds From Stock Options Exercised In Other Current Assets ProceedsFromStockOptionsExercisedInOtherCurrentAssets	73000	USD
CY2019Q1	agio	Public Offering Costs In Other Assets PublicOfferingCostsInOtherAssets	0	USD
CY2018Q1	agio	Public Offering Costs In Other Assets PublicOfferingCostsInOtherAssets	158000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	707800000	USD
CY2019Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2018Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	604830000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	330000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	812000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	604348000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	737090000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	33000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2204000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	734919000	USD
CY2019Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	148	security
CY2018Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	242	security
CY2019Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	362600000	USD
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	639300000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2267000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	788000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	61000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	81000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	2328000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	869000	USD
CY2019Q1	agio	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P6Y
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3100000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3100000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8576000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	13096000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13434000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	15798000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	17040000	USD
CY2019Q1	agio	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	17542000	USD
CY2019Q1	agio	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	2951000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88437000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P5Y10M24D
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88437000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13303000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	75134000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	12759000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	13135000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	13473000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	15552000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	17145000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	19223000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	91287000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5201000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20843000	USD
CY2019Q1	agio	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	23588000	USD
CY2018Q4	agio	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	14777000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6774000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5441000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1636000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1086000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37199000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42147000	USD
CY2018Q4	agio	Contract With Customer Contractual Adjustment Reserve ContractWithCustomerContractualAdjustmentReserve	592000	USD
CY2018Q4	agio	Contract With Customer Rebate Reserve ContractWithCustomerRebateReserve	325000	USD
CY2018Q4	agio	Contract With Customer Right To Recover Product Reserve ContractWithCustomerRightToRecoverProductReserve	334000	USD
CY2018Q4	agio	Contract With Customer Total Allowances And Reserves ContractWithCustomerTotalAllowancesAndReserves	1251000	USD
CY2019Q1	agio	Current Year Provision For Contractual Adjustments CurrentYearProvisionForContractualAdjustments	1265000	USD
CY2019Q1	agio	Current Year Provisions For Rebate Reserve CurrentYearProvisionsForRebateReserve	421000	USD
CY2019Q1	agio	Provision For Right To Recover Product In Current Year ProvisionForRightToRecoverProductInCurrentYear	215000	USD
CY2019Q1	agio	Contract With Customer Current Year Reserve Provisions ContractWithCustomerCurrentYearReserveProvisions	1901000	USD
CY2019Q1	agio	Prior Year Provision For Contractual Adjustments PriorYearProvisionForContractualAdjustments	8000	USD
CY2019Q1	agio	Prior Year Provisions For Rebate Reserve PriorYearProvisionsForRebateReserve	0	USD
CY2019Q1	agio	Provision For Right To Recover Product In Prior Years ProvisionForRightToRecoverProductInPriorYears	0	USD
CY2019Q1	agio	Contract With Customer Prior Years Reserve Provisions ContractWithCustomerPriorYearsReserveProvisions	8000	USD
CY2019Q1	agio	Contract With Customer Contract Adjustment Recoveries Current Year ContractWithCustomerContractAdjustmentRecoveriesCurrentYear	756000	USD
CY2019Q1	agio	Contract With Customer Rebate Reserve Recoveries In Current Year ContractWithCustomerRebateReserveRecoveriesInCurrentYear	0	USD
CY2019Q1	agio	Contract With Customer Right To Recover Product Current Year Recoveries ContractWithCustomerRightToRecoverProductCurrentYearRecoveries	0	USD
CY2019Q1	agio	Contract With Customer Current Year Reserve Recoveries ContractWithCustomerCurrentYearReserveRecoveries	756000	USD
CY2019Q1	agio	Contract With Customer Contract Adjustment Recoveries Prior Year ContractWithCustomerContractAdjustmentRecoveriesPriorYear	598000	USD
CY2019Q1	agio	Contract With Customer Rebate Reserve Recoveries In Prior Years ContractWithCustomerRebateReserveRecoveriesInPriorYears	150000	USD
CY2019Q1	agio	Contract With Customer Right To Recover Product Prior Year Recoveries ContractWithCustomerRightToRecoverProductPriorYearRecoveries	0	USD
CY2019Q1	agio	Contract With Customer Prior Years Reserve Recoveries ContractWithCustomerPriorYearsReserveRecoveries	748000	USD
CY2019Q1	agio	Contract With Customer Contractual Adjustment Reserve ContractWithCustomerContractualAdjustmentReserve	511000	USD
CY2019Q1	agio	Contract With Customer Rebate Reserve ContractWithCustomerRebateReserve	596000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	5076000	USD
CY2019Q1	agio	Contract With Customer Right To Recover Product Reserve ContractWithCustomerRightToRecoverProductReserve	549000	USD
CY2019Q1	agio	Contract With Customer Total Allowances And Reserves ContractWithCustomerTotalAllowancesAndReserves	1656000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	303000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	326000	USD
CY2019Q1	agio	Contract With Customer Allowance And Reserves Liability ContractWithCustomerAllowanceAndReservesLiability	1353000	USD
CY2018Q4	agio	Contract With Customer Allowance And Reserves Liability ContractWithCustomerAllowanceAndReservesLiability	925000	USD
CY2019Q1	agio	Contract With Customer Total Allowances And Reserves ContractWithCustomerTotalAllowancesAndReserves	1656000	USD
CY2018Q4	agio	Contract With Customer Total Allowances And Reserves ContractWithCustomerTotalAllowancesAndReserves	1251000	USD
CY2019Q1	agio	Contractwith Customer Asset Revenue Recognized ContractwithCustomerAssetRevenueRecognized	11047000	USD
CY2019Q1	agio	Contract With Customer Asset Proceeds From Collection Of Receivables ContractWithCustomerAssetProceedsFromCollectionOfReceivables	11768000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4355000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16410000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5984000	USD
CY2019Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	21000	USD
CY2018Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	323000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	83800000	USD
CY2018Q1	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	0	USD
CY2019Q1	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	0	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5416069	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	60.10
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1357189	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	57.47
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	106859	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	39.45
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	183526	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	64.12
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6482873	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	59.77
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3269079	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	57.85
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6482873	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	59.77
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18108000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14522000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18108000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14522000	USD
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7198813	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7198813	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6515743	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6515743	shares

Files In Submission

Name	View Source	Status
0001439222-19-000009-index-headers.html	Edgar Link	pending
0001439222-19-000009-index.html	Edgar Link	pending
0001439222-19-000009.txt	Edgar Link	pending
0001439222-19-000009-xbrl.zip	Edgar Link	pending
agio-20190331.htm	Edgar Link	pending
agio-20190331.xsd	Edgar Link	pending
agio-20190331_cal.xml	Edgar Link	unprocessable
agio-20190331_def.xml	Edgar Link	unprocessable
agio-20190331_htm.xml	Edgar Link	completed
agio-20190331_lab.xml	Edgar Link	unprocessable
agio-20190331_pre.xml	Edgar Link	unprocessable
exhibit31-1x03x31x19.htm	Edgar Link	pending
exhibit31-2x03x31x19.htm	Edgar Link	pending
exhibit32-1x03x31x19.htm	Edgar Link	pending
exhibit32-2x03x31x19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGIO
Agios Pharmaceuticals Inc Stock $agio

2019 Q2 Form 10-Q Financial Statement

#000143922219000009 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGIO Agios Pharmaceuticals Inc Stock $agio

2019 Q2 Form 10-Q Financial Statement

#000143922219000009 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGIO
Agios Pharmaceuticals Inc Stock $agio